Загрузка...
Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy
Background: Hyperglycemia occurs in cancer patients receiving high-dose steroids with cyclophosphamide, doxorubicin, vincristine, and dexamethasone (hyper-CVAD) protocol. The purpose of our study was to determine insulin requirements in patients with hyperglycemia on hyper-CVAD therapy using a syste...
Сохранить в:
| Опубликовано в: : | Diabetes Technol Ther |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc.
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4241952/ https://ncbi.nlm.nih.gov/pubmed/25321387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2014.0115 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|